Loading quotes...
Forecast
There is no analyst data available for this company.
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
Iconic Labs converts debenture into 458,716 ordinary shares
Iconic Labs has received a conversion notice dated 1 June under which 458,716 ordinary shares will be issued at a conversion price of £0.0109. The nominal amount of the issue is £5,000. The company has applied for admission of the new shares to trading on the Main Market of the London Stock Exchange, expected from 8 June. After the issue the issued share capital will rise to 16,039,907 ordinary shares, which is also the total number of voting rights. » More on de.investing.com
Financials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 0 | - |
| Gross profit | 0 | - |
| Net profit | -323.92K | - |
| EBITDA | -278.16K | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €305.01K |
Number of shares | 18.42M |
52-week high/low | €0.0596 - €0.0127 |
| Dividends | No |
Beta | 0.99 |
P/E ratio | -0.37 |
PEG ratio | -0.01 |
P/B ratio | -0.05 |
P/S ratio | 0.00 |
Company profile
Iconic Labs Plc provides consulting and agency services. The company offers advisory services to clients on their businesses; and delivers campaigns, as well as provides creative services to its clients. Its activities include monthly insights, content creation and distribution, post campaign analysis, and combining with online media brands. The company was formerly known as WideCells Group PLC and changed its name to Iconic Labs Plc in July 2019. Iconic Labs Plc was founded in 2012 and is based in London, the United Kingdom.
| Name | ICONIC LABS PLC LS-,00001 |
| CEO | John Forbes Farquharson |
| Headquarters | London,
gl United Kingdom |
| Website | |
| IPO | 07/27/2016 |
| Employees | 3 |
Ticker symbols
| Exchange | Symbol |
|---|---|
London Stock Exchange | ICON.L |
Frankfurt | W0G.F |
London | ICON.L |